Current through Register Vol. XLI, No. 44, November 1, 2024
Section 64-52-5 - Circumstances Under WhichAdministration Of Pertussis Vaccine Should BeDelayed5.1. Administration of the pertussis vaccine should be delayed under any of the following circumstances: (a) an individual exhibits a severe febrile illness;(b) an individual is receiving immunosuppresive therapy, including irradiation, antimetabolites, corticosteroids, alkylating agents, or cytotoxic drugs;(c) an individual has a history of seizure and it has not been determined that there is not an evolving neurologic disorder present; or(d) it is suspected, although not confirmed, that an individual has experienced a major adverse reaction.5.2. General or special use guidelines (a recommended immunization schedule based on data collected by the Advisory Committee on Immunization Practices of the United States Public Health Service and the Committee on Infectious Diseases of the American Academy of Pediatrics) provided by the department to local and county health departments should be consulted when a health care provider is considering the administration of pertussis vaccine to individuals in the circumstances described in Section 5.1.